Adefovir and lamivudine combination therapy is superior to ADV monotherapy for lamivudine-resistant patients with HBeAG-negative chronic hepatitis B
Titel:
Adefovir and lamivudine combination therapy is superior to ADV monotherapy for lamivudine-resistant patients with HBeAG-negative chronic hepatitis B
Auteur:
Lampertico, P. Marzano, A. Levrero, M. Santantonio, T. Di Marco, V. Brunetto, M. Andreone, P. Sagnelli, E. Fagiuoli, S. Mazzella, G. Raimondo, G. Gaeta, G.B. Ascione, A.